Association of Dipeptidyl Peptidase-4 Inhibitors with Glaucoma Risk in Patients with Type 2 Diabetes: A Nationwide Cohort Study

Association of Dipeptidyl Peptidase-4 Inhibitors with Glaucoma Risk in Patients with Type 2 Diabetes: A Nationwide Cohort Study

Purpose: To investigate the association between dipeptidyl peptidase-4 inhibitors (DPP4is) and the risk of primary open-angle glaucoma (POAG) and normal tension glaucoma (NTG) in patients with type 2 diabetes mellitus (T2DM). Design: Retrospective cohort study. Subjects: A total of 582 710 patients...

Full description

Saved in:
Bibliographic Details
Main Authors: Yi-An Lu, MD, Peng-Tai Tien, MD, PhD, Yih-Dih Cheng, PhD, Yow-Wen Hsieh, PhD, Der-Yang Cho, MD, Shang-Feng Tsai, MD, PhD, Chien-Hsiang Weng, MD, MPH, Heng-Jun Lin, Hui-Ju Lin, MD, PhD, I-Jong Wang, MD, PhD, Chien-Chih Chou, MD, PhD
Format: Article
Language:English
Published: Elsevier 2025-09-01
Series:Ophthalmology Science
Subjects:
Dipeptidyl peptidase-4 inhibitors
Normal tension glaucoma
Ocular hypertension
Primary open-angle glaucoma
Type 2 diabetes mellitus
Online Access:http://www.sciencedirect.com/science/article/pii/S2666914525001253
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

http://www.sciencedirect.com/science/article/pii/S2666914525001253

Similar Items